MDT - Medtronic plc

NYSE - NYSE Delayed Price. Currency in USD
96.00
-1.15 (-1.18%)
At close: 4:00PM EDT

96.20 +0.20 (0.21%)
After hours: 5:54PM EDT

Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close97.15
Open97.43
Bid96.10 x 900
Ask96.45 x 1100
Day's Range94.91 - 98.14
52 Week Range72.13 - 122.15
Volume6,152,168
Avg. Volume7,687,556
Market Cap128.656B
Beta (5Y Monthly)0.70
PE Ratio (TTM)23.94
EPS (TTM)4.01
Earnings DateAug 25, 2020
Forward Dividend & Yield2.32 (2.39%)
Ex-Dividend DateJun 25, 2020
1y Target Est112.87
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-21% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Hedge Funds Cashed Out Of Medtronic plc (MDT) During The Crash
    Insider Monkey

    Hedge Funds Cashed Out Of Medtronic plc (MDT) During The Crash

    The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filings submitted by hedge funds and prominent investors. These filings show these funds' portfolio positions as of March 31st, 2020. […]

  • GuruFocus.com

    5 Companies Boosting Dividend Payments

    Chubb, Clorox, Flower Foods, Medtronic and Northrop Grumman have all recently raised their dividends Continue reading...

  • 3 Medical-Supply Stocks You Should Own Besides Medtronic
    Motley Fool

    3 Medical-Supply Stocks You Should Own Besides Medtronic

    MSA Safety, Fresnius Medical Care, and LeMaitre Vascular are well-priced stocks on the rise with solid dividends.

  • GlobeNewswire

    Medtronic CEO Geoff Martha to Speak at Bernstein Strategic Decisions Conference

    Medtronic plc (MDT), the global leader in medical technology, today announced that it will participate in the Bernstein 36th Annual Strategic Decisions Conference, held virtually, on Friday, May 29, 2020. Geoff Martha, chief executive officer of Medtronic, will make a presentation and will answer questions about the company beginning at 9:00 a.m. EDT (8:00 a.m. CDT). Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world.

  • GlobeNewswire

    Medtronic Guardian™ Connect Continuous Glucose Monitoring (CGM) System for Diabetes Now Compatible with Android Devices

    Medtronic plc (MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval for the Android™ version of its Guardian™ Connect continuous glucose monitoring (CGM) system. The Guardian Connect system is a standalone CGM system that alerts patients of potential high or low sensor glucose events up to 60 minutes in advance and provides confidence to people living with diabetes who worry about fluctuating glucose levels and dangerous low glucose events.

  • Medtronic (MDT) Q4 Earnings Miss Estimates, Revenues Beat
    Zacks

    Medtronic (MDT) Q4 Earnings Miss Estimates, Revenues Beat

    Medtronic (MDT) demonstrates weak fiscal fourth-quarter performances at CER, attributable to dismal show in all major business segments and geographies.

  • Thomson Reuters StreetEvents

    Edited Transcript of MDT earnings conference call or presentation 21-May-20 12:00pm GMT

    Q4 2020 Medtronic PLC Earnings Call

  • Medtech Giant Tumbles As Coronavirus Pandemic Slams Quarterly Results
    Investor's Business Daily

    Medtech Giant Tumbles As Coronavirus Pandemic Slams Quarterly Results

    The coronavirus pandemic slammed Medtronic in its fiscal fourth quarter as the medical technology company posted a 26% sales decline and 62% slide in earnings — leading MDT stock to drop.

  • Coronavirus update: Global case tally passes 5 million; U.S. scientist says don’t rely on a vaccine, job losses continue
    MarketWatch

    Coronavirus update: Global case tally passes 5 million; U.S. scientist says don’t rely on a vaccine, job losses continue

    The global case tally for the coronavirus that causes COVID-19 passed 5 million on Thursday after the biggest one-day increase since the start of the outbreak, as a top U.S. scientist cautioned that people should not rely on a vaccine and the labor market continued to show massive job losses.

  • TheStreet.com

    Medtronic Misses Quarterly Estimates, Raises Dividend

    Medtronic shares were falling Thursday after the medical device manufacturer reported fourth quarter results that missed estimates as revenue fell 26% year over year in the quarter. The Dublin-based company reported fourth quarter earnings of 58 cents per share on revenue of $6 billion. Medtronic shares fell more than 2% to $96.10 in trading on Thursday.

  • Medtronic (MDT) Misses Q4 Earnings Estimates
    Zacks

    Medtronic (MDT) Misses Q4 Earnings Estimates

    Medtronic (MDT) delivered earnings and revenue surprises of -1.69% and 1.20%, respectively, for the quarter ended April 2020. Do the numbers hold clues to what lies ahead for the stock?

  • MarketWatch

    Medtronic earnings fall short of estimates, but company raises quarterly dividend

    Medical device company Medtronic Plc said Thursday it had net income of $646 million, or 48 cents a share, in its fiscal fourth quarter to April 24, down from $1.172 billion, or 87 cents a share, in the year-earlier period. Adjusted per-share earnings came to 58 cents, below the 96 cents FactSet consensus. Revenue fell 26% to $6.0 billion, below the $6.9 billion FactSet consensus. The numbers were in line with an update provided by the company on April 21, which detailed the impact of the coronavirus pandemic on operations and financials. "Medtronic's results were also consistent with the impact felt across the MedTech industry from deferred procedures as a result of the pandemic," the Dublin-based company said in a statement. "Medtronic is in a strong financial position, as represented by the increase in its cash dividend announced today, and the company continues to drive its long-term strategies." The company's board approved an increase in the quarterly dividend to 58 cents from 54 cents. It is not offering guidance because of the uncertainty created by the pandemic. Shares fell 1.1% premarket and are down 14% in the year to date, while the S&P 500 has fallen 8%.

  • Reuters

    Medtronic warns of sales hit as people delay non-emergency surgeries

    Medical device makers have borne the brunt of the coronavirus outbreak as federal and state guidelines ask for elective surgeries such as hip and knee replacements and certain heart procedures to be delayed, sapping the demand for devices used in the surgeries. The company expects a slow recovery in its restorative therapies unit, which houses neuro-stimulation implants to treat chronic pain, and heart device unit, which sells valves. "We currently expect first quarter revenue growth to be modestly worse than the fourth quarter," said Chief Financial Officer Karen Parkhill.

  • GlobeNewswire

    Medtronic Reports Fourth Quarter and Fiscal Year 2020 Financial Results; Announces Dividend Increase

    Medtronic plc (MDT) today announced financial results for its fourth quarter and fiscal year 2020, which ended April 24, 2020. Medtronic’s results were also consistent with the impact felt across the MedTech industry from deferred procedures as a result of the pandemic. Medtronic is in a strong financial position, as represented by the increase in its cash dividend announced today, and the company continues to drive its long-term strategies.

  • Medtronic Launches Kyphon Cannula for Balloon Kyphoplasty
    Zacks

    Medtronic Launches Kyphon Cannula for Balloon Kyphoplasty

    Medtronic's (MDT) new cannula will complement its entire portfolio of balloon kyphoplasty products, including Kyphon Xpander II Inflatable Bone Tamps.

  • GlobeNewswire

    New Directional Cannula Provides More Flexibility and Control to Balloon Kyphoplasty Procedures

    DUBLIN, May 19, 2020 -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the U.S. launch of Kyphon Assist™ Directional Cannula for use with.

  • Moody's

    Covidien International Finance S.A. -- Moody's announces completion of a periodic review of ratings of Medtronic, Inc.

    Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Medtronic, Inc. New York, May 18, 2020 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Medtronic, Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

  • Medtronic Stock Is in 'No Man's Land'
    TheStreet.com

    Medtronic Stock Is in 'No Man's Land'

    During Friday's Mad Money program Jim Cramer told viewers that he was worried about earnings for Medtronic plc on Thursday. The daily On-Balance-Volume (OBV) line has improved slightly from late March but it is at least moving in the right direction. The weekly OBV line is still pointed down from January and the MACD oscillator is still bearish and not positioned yet for a cover shorts buy signal.

  • GlobeNewswire

    Jeffrey J. Popma, M.D. to Join Medtronic as Vice President and Chief Medical Officer for Coronary, Renal Denervation, and Structural Heart Businesses

    Medtronic plc (MDT), the global leader in medical technology, today announced Jeffrey J. Popma, M.D., professor of medicine at Harvard Medical School and director of interventional cardiology at Beth Israel Deaconess Medical Center in Boston, will join Medtronic as Vice President and Chief Medical Officer (CMO) supporting the Coronary, Renal Denervation, and Structural Heart businesses at Medtronic. As an academic interventional cardiologist for over two decades, Dr. Popma will provide medical leadership across Coronary, Renal Denervation, and Structural Heart, serve as a strategic advisor for cardiovascular device innovation, and assist in the development of an expanding clinical research portfolio, leveraging his deep expertise in interventional cardiology and transcatheter-based therapies.

  • Will Ventilator Sales Drive Medtronic's (MDT) Q4 Earnings?
    Zacks

    Will Ventilator Sales Drive Medtronic's (MDT) Q4 Earnings?

    Medtronic (MDT) might have registered lower demand for its emergency procedures in Q4 with patients trying to avoid any non-COVID-19 emergency treatment.

  • Barrons.com

    Merck, Medtronic, and Other Health-Care Stocks Widely Owned by ESG Funds Outperform

    Health-care stocks that were popular in ESG funds tended to score better on ESG issues than other stocks in the sector in conventional funds, according to a study.

  • Broken Ventilators Spark Push to End Limits on Who Can Fix Them
    Bloomberg

    Broken Ventilators Spark Push to End Limits on Who Can Fix Them

    (Bloomberg) -- A group of state officials has an idea to expand the availability of ventilators and other equipment hospitals need to treat coronavirus patients: let more medical facilities fix the ones they have.In a letter to equipment manufacturers, the state treasurers of Pennsylvania, Colorado, Delaware, Illinois, and Rhode Island said hospitals sometimes had to wait longer than a week for technicians under their maintenance contracts to fix equipment. Manufacturers have refused to supply parts to anyone who hasn’t undergone the expensive company training.“In a global pandemic with this kind of urgency and this kind of devastation, where every second counts, there shouldn’t be a single ventilator in any hospital that can’t be used because of these restrictions,” Pennsylvania State Treasurer Joe Torsella said in an interview.Torsella led the group calling on manufacturers to release all repair manuals and service keys and to allow hospitals to use technicians of their choice instead of those required under maintenance contracts. The effort also turned a spotlight on an issue that some consumer rights groups are hoping could lead to a more permanent change.Twenty states are considering legislation that would give consumers more rights to repair, resell and modify products they buy, whether it’s more access to the software on John Deere farm tractors, going outside Apple Inc.’s “Genius Bar” to fix a broken iPhone, or selling digital books after they’ve been read. Some, but not all, also include provisions that would cover medical equipment, which are tightly regulated by the U.S. Food and Drug Administration.The pandemic may give the movement a boost because of the outcry over reports of broken or unavailable ventilators. In April, the U.S. Public Interest Research Group sent a petition with 43,000 signatures calling on manufacturers to release repair information.Hundreds of biomedical engineers, also known as biomeds, signed a letter to be released Monday by PIRG that calls for greater access to service materials and for making product-specific training “on fair and reasonable terms.”As the outbreak spread over the past month, some medical equipment makers such as Medtronic Plc and General Electric Co. agreed to turn over manuals and other information to ensure hospitals have what they need.The companies, along with Draegerwerk AG, sell medical equipment for as much as $1 million or more for each machine. Draegerwerk, which biomeds said has particularly strict rules, is projecting an increase in sales as hospitals need more devices to treat coronavirus patients. Even more profitable are the required service contracts to keep complicated equipment like ventilators, patient monitors, and MRI machines working.“We provide 24/7 technical support to the hospitals we supply as well as rapid on-site service,” said Marion Varec, a spokeswoman for Draegerwerk. “In fact, we provide manuals, to the extent consistent with FDA quality standards. We listen to our customers and support their needs.”Legislative proposals have been strongly fought by the industries affected, and the medical device industry has been among the most vocal. It’s trying to get Congress to pass legislation that would impose more stringent requirements on hospital and independent biomedical technicians, or biomeds. Instead, the U.S. Food and Drug Administration was told to investigate whether there was a difference in the quality of service -- the agency determined in 2018 that there was no fall off in quality of repairs when it was done by in-house hospital technicians or trained independent biomeds.Among those weighing in on behalf of the biomeds was the Defense Department, which called the profit margins on maintenance “astounding” and said the markup for parts could be more than 1000%.Leticia Reynolds, president of the Colorado Association of Biomedical Equipment Technicians and a member of the U.S. Army Reserve, said there’s a big difference in what you can do at military hospitals and at civilian ones.“In the military, you can work on pretty much anything,” said Reynolds. In the civilian sector, “If you haven’t been to their school, they say ‘We won’t help you,’ or ‘You can’t buy parts.”’The industry said its employees are held to a higher standard than those working for hospitals or with third-party repair firms, known collectively as independent servicing organizations, and its efforts were to put all technicians on the same level.“Currently, only servicing activities performed by medical device manufacturers are held to any quality, safety, or regulatory requirements by the FDA,” said Peter Weems, Director of Policy & Strategy at the Medical Imaging and Technology Alliance. Independent servicing organizations are not required to register with the FDA, report deaths or serious injuries, or adopt quality management systems.Some hospital officials are critical of the medical equipment industry.“It’s not about safety, it’s about maintaining a business advantage,” said Patrick Flaherty, vice president of supplier performance at Pittsburgh-based UPMC, a group of more than 40 hospitals, who called the manufacturers “monopolists and cartels.” “It’s absolutely repulsive if you try to cloak it under patient safety.”Hacking ThreatOthers say that the additional protections are needed with regard to complicated medical equipment -- especially as more systems become networked and vulnerable to hacking.“This is life-saving and life-sustaining equipment,” said Nick Lewis, systems director of environmental safety management and compliance at Baptist Memorial Health Care in Memphis, Tennessee. “Having tight controls -- whether that be passwords, or when they update software -- they have to be pretty tight with that stuff or we could potentially put ourselves at risk with cyber issues.”Amid a dire shortage of personal protective gear for doctors, nurses and other first responders through the country when the Covid-19 virus migrated from Asia and Europe, U.S. hospitals also found ventilators in short supply and some delivered from the National Stockpile broken. Hospitals and critical care facilities had to adapt other equipment, such as reconfiguring anesthesia machines and transport ventilators.Hospitals PreparedMassachusetts General Hospital sent a team to inspect and repair the entire contingent of ventilators the state received from the National Stockpile, knowing smaller hospitals wouldn’t have the trained technicians, said Paul Biddinger, director of emergency preparedness at the Boston hospital.“Early on, as we saw the coronavirus emerging as a threat, we tried very hard to anticipate what the impact on our system could be,” Biddinger said.At the Johnson Memorial Health in Johnson, Indiana, the hospital found powered air-purifying respirators needed by health-care professionals in the Covid unit that were so old there was no way to buy the connector hoses that pump fresh air, said marketing director Jeff Dutton.“Someone knew a small business in Franklin that had a 3D printer and was able to replicate the part perfectly,” Dutton said.Manufacturers initially kept to their long-standing policies when it came to access to manuals, software codes and parts. But as the scope of the crisis grew, many began easing restrictions, posting their closely kept service manuals on their websites, or dropping objections to having them posted on sites such as iFixit.com, which crowd sources manuals.It’s unknown whether they will try to pull them back once the pandemic is over. Jared Wilson, co-founder of Insight HTM LLC, which does repairs and maintenance at ambulatory surgical centers, said he is bizarrely “grateful” for the pandemic.“Typically we’re in what was the morgue, the bottommost corner of the hospital,” Wilson said. “This really has brought to light the issue of maintenance of equipment. We’ve been striving for this for so long.”Flaherty said the work being done at hospitals and critical care centers around the world spotlight that some of the rules are unnecessary.“If Covid did not create a learning platform for people, then it’s a missed opportunity,” Flaherty said.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.